FDA Oncology Announcements

Asparagine-specific enzyme × Lymphoid × Clear all

2 Announcements

FDA approves asparaginase erwinia chrysanthemi (recombinant) for leukemia and lymphoma

Drug: Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) · Asparagine-specific enzyme
Conditions: LymphoidOther hematologic neoplasm

FDA Approves pegaspargase (Oncaspar, Enzon Pharmaceuticals, Inc) for the first-line treatment of patients with acute lymphoblastic leukemia

Drug: Oncaspar (pegaspargase) · Asparagine-specific enzyme
Conditions: LymphoidOther hematologic neoplasm